FOR IMMEDIATE RELEASE
InVentiv Clinical Solutions Joins Medidata Solutions’ ASPire to Win Partner Program
Global CRO Pursues Most Advanced Medidata Accreditation to Expand EDC Services
NEW YORK, N.Y. – December 7, 2009 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that inVentiv Clinical Solutions, LLC (inVentiv Clinical), the contract research organization (CRO) division of inVentiv Health (NASDAQ: VTIV), has joined Medidata’s ASPire to Win® program for CROs and other service providers. The partnership enables inVentiv to expand its clinical technology expertise and services and specialize in the delivery of the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) solution.
inVentiv Clinical offers a unique set of complete clinical research services to the pharmaceutical, biotech and medical device industries, with a commitment to fitting its people, process and systems around customers’ needs. In response to the growth of its CRO business and increasing customer demand for Medidata Rave, inVentiv Clinical joined the ASPire to Win program to offer a range of Rave-related services to clinical trial sponsors. In addition to providing better access to clinical data that will support improved decision-making, inVentiv Clinical also anticipates using Rave to enhance its study start-up processes as well as patient and investigator recruitment. inVentiv Clinical also intends to integrate Rave with clinical technologies from its existing suite of applications to deliver accelerated trial results for sponsors.
Medidata’s ASPire to Win program selects, trains and accredits CROs and other clinical service providers to deliver Medidata Rave clinical trial technology along with their own project and data management expertise. The program offers the choice of four enablement levels—Rave Aware, Rave Ready, Rave Accredited and Rave Accredited Plus. inVentiv Clinical is currently working towards Rave Accredited Plus, training teams in both North America and Asia.
“Sponsors are increasingly selecting Medidata Rave as their EDC technology of choice, and by partnering with Medidata through the ASPire to Win program, we will be able to address this demand while complementing our existing high-quality and flexible service model,” said Scott Treiber, Executive Vice President, inVentiv Clinical Solutions. “Our relationship with Medidata on a global scale will enable us to accelerate clinical results for our clients and more importantly, help improve the lives of patients.”
“inVentiv Clinical is an industry leader in clinical research outsourcing and is a natural partner for us,” said Graham Bunn, Vice President for Global CRO Partnerships, Medidata Solutions. “As sponsors increasingly rely on CROs as trusted advisors in clinical development, inVentiv Clinical and Medidata share a vision of leveraging clinical solutions to streamline and enhance trials.”
Medidata first announced ASPire to Win in April 2005 as a partner program designed to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, ASPire to Win has grown to include 24 partners, ranging from smaller clinical consultancies to large, global CROs. For more information about the ASPire to Win program, visit www.mdsol.com/partnerships/cros.htm.
About inVentiv Clinical Solutions
inVentiv Clinical Solutions (www.inVentivClinical.com) operates with a simple formula to continuously exceed our clients’ needs. We have “Built to FIT” solutions to deliver flexibility to customers’ needs, with infrastructure, intelligence and integrity and tailored solutions that accelerate results. We allow clients to enjoy the greatest control and flexibility through unmatched access to high quality clinical resources. We offer full clinical development solutions in both, full service and functional structures to the pharmaceutical, biotechnology and medical device industries.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com